Medical Care

Global Whole Genome and Exome Sequencing Market Research Report 2025

The global market for Whole Genome and Exome Sequencing was valued at US$ 360 million in the year 2024 and is projected to reach a revised size of US$ 758 million by 2031, growing at a CAGR of 11.4% during the forecast period.
Whole Genome Sequencing sequences the complete DNA of an organism. In the case of a human this corresponds to about three billion base pairs of DNA. Whole genome sequencing entails sequencing all coding (exons) and noncoding (intron) nuclear DNA as well as mitochondrial DNA. This allows researchers to generate large quantities of data, which can then be analyzed.The exome makes up only 1.5% of the whole human genome, however ALL protein coding genes are found in the exome. Since most genetic disorders are correlated with mutations in protein coding genes, most physicians and scientists who use sequencing technologies for diagnostic purposes start with an analysis of the exome.
North American market for Whole Genome and Exome Sequencing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Whole Genome and Exome Sequencing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Whole Genome and Exome Sequencing in Hospitals and Clinics is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Whole Genome and Exome Sequencing include Eurofins Scientific SE, Agilent Technologies, Inc, Beijing Genomics Institute (BGI), Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc, GENEWIZ, Inc, Illumina, Inc, Laboratory Corporation of America Holdings, Novogene Corporation, Oxford Nanopore Technologies, Inc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Whole Genome and Exome Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Whole Genome and Exome Sequencing.
The Whole Genome and Exome Sequencing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Whole Genome and Exome Sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Whole Genome and Exome Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eurofins Scientific SE
Agilent Technologies, Inc
Beijing Genomics Institute (BGI)
Hoffmann-La Roche Ltd
Bio-Rad Laboratories, Inc
GENEWIZ, Inc
Illumina, Inc
Laboratory Corporation of America Holdings
Novogene Corporation
Oxford Nanopore Technologies, Inc
Pacific Biosciences of California, Inc
QIAGEN N.V
Thermo Fisher Scientific Inc
Cytiva
Segment by Type
By Product
By Workflow
Segment by Application
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Diagnostic Labs
Research Centres, Academia and Government Institutes
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Whole Genome and Exome Sequencing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Whole Genome and Exome Sequencing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 By Product
1.2.3 By Workflow
1.3 Market by Application
1.3.1 Global Whole Genome and Exome Sequencing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals and Clinics
1.3.3 Pharmaceutical and Biotechnology Companies
1.3.4 Diagnostic Labs
1.3.5 Research Centres, Academia and Government Institutes
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Whole Genome and Exome Sequencing Market Perspective (2020-2031)
2.2 Global Whole Genome and Exome Sequencing Growth Trends by Region
2.2.1 Global Whole Genome and Exome Sequencing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Whole Genome and Exome Sequencing Historic Market Size by Region (2020-2025)
2.2.3 Whole Genome and Exome Sequencing Forecasted Market Size by Region (2026-2031)
2.3 Whole Genome and Exome Sequencing Market Dynamics
2.3.1 Whole Genome and Exome Sequencing Industry Trends
2.3.2 Whole Genome and Exome Sequencing Market Drivers
2.3.3 Whole Genome and Exome Sequencing Market Challenges
2.3.4 Whole Genome and Exome Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Whole Genome and Exome Sequencing Players by Revenue
3.1.1 Global Top Whole Genome and Exome Sequencing Players by Revenue (2020-2025)
3.1.2 Global Whole Genome and Exome Sequencing Revenue Market Share by Players (2020-2025)
3.2 Global Whole Genome and Exome Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Whole Genome and Exome Sequencing Revenue
3.4 Global Whole Genome and Exome Sequencing Market Concentration Ratio
3.4.1 Global Whole Genome and Exome Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Whole Genome and Exome Sequencing Revenue in 2024
3.5 Global Key Players of Whole Genome and Exome Sequencing Head office and Area Served
3.6 Global Key Players of Whole Genome and Exome Sequencing, Product and Application
3.7 Global Key Players of Whole Genome and Exome Sequencing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Whole Genome and Exome Sequencing Breakdown Data by Type
4.1 Global Whole Genome and Exome Sequencing Historic Market Size by Type (2020-2025)
4.2 Global Whole Genome and Exome Sequencing Forecasted Market Size by Type (2026-2031)
5 Whole Genome and Exome Sequencing Breakdown Data by Application
5.1 Global Whole Genome and Exome Sequencing Historic Market Size by Application (2020-2025)
5.2 Global Whole Genome and Exome Sequencing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Whole Genome and Exome Sequencing Market Size (2020-2031)
6.2 North America Whole Genome and Exome Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Whole Genome and Exome Sequencing Market Size by Country (2020-2025)
6.4 North America Whole Genome and Exome Sequencing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Whole Genome and Exome Sequencing Market Size (2020-2031)
7.2 Europe Whole Genome and Exome Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Whole Genome and Exome Sequencing Market Size by Country (2020-2025)
7.4 Europe Whole Genome and Exome Sequencing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Whole Genome and Exome Sequencing Market Size (2020-2031)
8.2 Asia-Pacific Whole Genome and Exome Sequencing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Whole Genome and Exome Sequencing Market Size by Region (2020-2025)
8.4 Asia-Pacific Whole Genome and Exome Sequencing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Whole Genome and Exome Sequencing Market Size (2020-2031)
9.2 Latin America Whole Genome and Exome Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Whole Genome and Exome Sequencing Market Size by Country (2020-2025)
9.4 Latin America Whole Genome and Exome Sequencing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Whole Genome and Exome Sequencing Market Size (2020-2031)
10.2 Middle East & Africa Whole Genome and Exome Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Whole Genome and Exome Sequencing Market Size by Country (2020-2025)
10.4 Middle East & Africa Whole Genome and Exome Sequencing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eurofins Scientific SE
11.1.1 Eurofins Scientific SE Company Details
11.1.2 Eurofins Scientific SE Business Overview
11.1.3 Eurofins Scientific SE Whole Genome and Exome Sequencing Introduction
11.1.4 Eurofins Scientific SE Revenue in Whole Genome and Exome Sequencing Business (2020-2025)
11.1.5 Eurofins Scientific SE Recent Development
11.2 Agilent Technologies, Inc
11.2.1 Agilent Technologies, Inc Company Details
11.2.2 Agilent Technologies, Inc Business Overview
11.2.3 Agilent Technologies, Inc Whole Genome and Exome Sequencing Introduction
11.2.4 Agilent Technologies, Inc Revenue in Whole Genome and Exome Sequencing Business (2020-2025)
11.2.5 Agilent Technologies, Inc Recent Development
11.3 Beijing Genomics Institute (BGI)
11.3.1 Beijing Genomics Institute (BGI) Company Details
11.3.2 Beijing Genomics Institute (BGI) Business Overview
11.3.3 Beijing Genomics Institute (BGI) Whole Genome and Exome Sequencing Introduction
11.3.4 Beijing Genomics Institute (BGI) Revenue in Whole Genome and Exome Sequencing Business (2020-2025)
11.3.5 Beijing Genomics Institute (BGI) Recent Development
11.4 Hoffmann-La Roche Ltd
11.4.1 Hoffmann-La Roche Ltd Company Details
11.4.2 Hoffmann-La Roche Ltd Business Overview
11.4.3 Hoffmann-La Roche Ltd Whole Genome and Exome Sequencing Introduction
11.4.4 Hoffmann-La Roche Ltd Revenue in Whole Genome and Exome Sequencing Business (2020-2025)
11.4.5 Hoffmann-La Roche Ltd Recent Development
11.5 Bio-Rad Laboratories, Inc
11.5.1 Bio-Rad Laboratories, Inc Company Details
11.5.2 Bio-Rad Laboratories, Inc Business Overview
11.5.3 Bio-Rad Laboratories, Inc Whole Genome and Exome Sequencing Introduction
11.5.4 Bio-Rad Laboratories, Inc Revenue in Whole Genome and Exome Sequencing Business (2020-2025)
11.5.5 Bio-Rad Laboratories, Inc Recent Development
11.6 GENEWIZ, Inc
11.6.1 GENEWIZ, Inc Company Details
11.6.2 GENEWIZ, Inc Business Overview
11.6.3 GENEWIZ, Inc Whole Genome and Exome Sequencing Introduction
11.6.4 GENEWIZ, Inc Revenue in Whole Genome and Exome Sequencing Business (2020-2025)
11.6.5 GENEWIZ, Inc Recent Development
11.7 Illumina, Inc
11.7.1 Illumina, Inc Company Details
11.7.2 Illumina, Inc Business Overview
11.7.3 Illumina, Inc Whole Genome and Exome Sequencing Introduction
11.7.4 Illumina, Inc Revenue in Whole Genome and Exome Sequencing Business (2020-2025)
11.7.5 Illumina, Inc Recent Development
11.8 Laboratory Corporation of America Holdings
11.8.1 Laboratory Corporation of America Holdings Company Details
11.8.2 Laboratory Corporation of America Holdings Business Overview
11.8.3 Laboratory Corporation of America Holdings Whole Genome and Exome Sequencing Introduction
11.8.4 Laboratory Corporation of America Holdings Revenue in Whole Genome and Exome Sequencing Business (2020-2025)
11.8.5 Laboratory Corporation of America Holdings Recent Development
11.9 Novogene Corporation
11.9.1 Novogene Corporation Company Details
11.9.2 Novogene Corporation Business Overview
11.9.3 Novogene Corporation Whole Genome and Exome Sequencing Introduction
11.9.4 Novogene Corporation Revenue in Whole Genome and Exome Sequencing Business (2020-2025)
11.9.5 Novogene Corporation Recent Development
11.10 Oxford Nanopore Technologies, Inc
11.10.1 Oxford Nanopore Technologies, Inc Company Details
11.10.2 Oxford Nanopore Technologies, Inc Business Overview
11.10.3 Oxford Nanopore Technologies, Inc Whole Genome and Exome Sequencing Introduction
11.10.4 Oxford Nanopore Technologies, Inc Revenue in Whole Genome and Exome Sequencing Business (2020-2025)
11.10.5 Oxford Nanopore Technologies, Inc Recent Development
11.11 Pacific Biosciences of California, Inc
11.11.1 Pacific Biosciences of California, Inc Company Details
11.11.2 Pacific Biosciences of California, Inc Business Overview
11.11.3 Pacific Biosciences of California, Inc Whole Genome and Exome Sequencing Introduction
11.11.4 Pacific Biosciences of California, Inc Revenue in Whole Genome and Exome Sequencing Business (2020-2025)
11.11.5 Pacific Biosciences of California, Inc Recent Development
11.12 QIAGEN N.V
11.12.1 QIAGEN N.V Company Details
11.12.2 QIAGEN N.V Business Overview
11.12.3 QIAGEN N.V Whole Genome and Exome Sequencing Introduction
11.12.4 QIAGEN N.V Revenue in Whole Genome and Exome Sequencing Business (2020-2025)
11.12.5 QIAGEN N.V Recent Development
11.13 Thermo Fisher Scientific Inc
11.13.1 Thermo Fisher Scientific Inc Company Details
11.13.2 Thermo Fisher Scientific Inc Business Overview
11.13.3 Thermo Fisher Scientific Inc Whole Genome and Exome Sequencing Introduction
11.13.4 Thermo Fisher Scientific Inc Revenue in Whole Genome and Exome Sequencing Business (2020-2025)
11.13.5 Thermo Fisher Scientific Inc Recent Development
11.14 Cytiva
11.14.1 Cytiva Company Details
11.14.2 Cytiva Business Overview
11.14.3 Cytiva Whole Genome and Exome Sequencing Introduction
11.14.4 Cytiva Revenue in Whole Genome and Exome Sequencing Business (2020-2025)
11.14.5 Cytiva Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Whole Genome and Exome Sequencing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of By Product
Table 3. Key Players of By Workflow
Table 4. Global Whole Genome and Exome Sequencing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Whole Genome and Exome Sequencing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Whole Genome and Exome Sequencing Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Whole Genome and Exome Sequencing Market Share by Region (2020-2025)
Table 8. Global Whole Genome and Exome Sequencing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Whole Genome and Exome Sequencing Market Share by Region (2026-2031)
Table 10. Whole Genome and Exome Sequencing Market Trends
Table 11. Whole Genome and Exome Sequencing Market Drivers
Table 12. Whole Genome and Exome Sequencing Market Challenges
Table 13. Whole Genome and Exome Sequencing Market Restraints
Table 14. Global Whole Genome and Exome Sequencing Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Whole Genome and Exome Sequencing Market Share by Players (2020-2025)
Table 16. Global Top Whole Genome and Exome Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Whole Genome and Exome Sequencing as of 2024)
Table 17. Ranking of Global Top Whole Genome and Exome Sequencing Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Whole Genome and Exome Sequencing Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Whole Genome and Exome Sequencing, Headquarters and Area Served
Table 20. Global Key Players of Whole Genome and Exome Sequencing, Product and Application
Table 21. Global Key Players of Whole Genome and Exome Sequencing, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Whole Genome and Exome Sequencing Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Whole Genome and Exome Sequencing Revenue Market Share by Type (2020-2025)
Table 25. Global Whole Genome and Exome Sequencing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Whole Genome and Exome Sequencing Revenue Market Share by Type (2026-2031)
Table 27. Global Whole Genome and Exome Sequencing Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Whole Genome and Exome Sequencing Revenue Market Share by Application (2020-2025)
Table 29. Global Whole Genome and Exome Sequencing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Whole Genome and Exome Sequencing Revenue Market Share by Application (2026-2031)
Table 31. North America Whole Genome and Exome Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Whole Genome and Exome Sequencing Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Whole Genome and Exome Sequencing Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Whole Genome and Exome Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Whole Genome and Exome Sequencing Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Whole Genome and Exome Sequencing Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Whole Genome and Exome Sequencing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Whole Genome and Exome Sequencing Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Whole Genome and Exome Sequencing Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Whole Genome and Exome Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Whole Genome and Exome Sequencing Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Whole Genome and Exome Sequencing Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Whole Genome and Exome Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Whole Genome and Exome Sequencing Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Whole Genome and Exome Sequencing Market Size by Country (2026-2031) & (US$ Million)
Table 46. Eurofins Scientific SE Company Details
Table 47. Eurofins Scientific SE Business Overview
Table 48. Eurofins Scientific SE Whole Genome and Exome Sequencing Product
Table 49. Eurofins Scientific SE Revenue in Whole Genome and Exome Sequencing Business (2020-2025) & (US$ Million)
Table 50. Eurofins Scientific SE Recent Development
Table 51. Agilent Technologies, Inc Company Details
Table 52. Agilent Technologies, Inc Business Overview
Table 53. Agilent Technologies, Inc Whole Genome and Exome Sequencing Product
Table 54. Agilent Technologies, Inc Revenue in Whole Genome and Exome Sequencing Business (2020-2025) & (US$ Million)
Table 55. Agilent Technologies, Inc Recent Development
Table 56. Beijing Genomics Institute (BGI) Company Details
Table 57. Beijing Genomics Institute (BGI) Business Overview
Table 58. Beijing Genomics Institute (BGI) Whole Genome and Exome Sequencing Product
Table 59. Beijing Genomics Institute (BGI) Revenue in Whole Genome and Exome Sequencing Business (2020-2025) & (US$ Million)
Table 60. Beijing Genomics Institute (BGI) Recent Development
Table 61. Hoffmann-La Roche Ltd Company Details
Table 62. Hoffmann-La Roche Ltd Business Overview
Table 63. Hoffmann-La Roche Ltd Whole Genome and Exome Sequencing Product
Table 64. Hoffmann-La Roche Ltd Revenue in Whole Genome and Exome Sequencing Business (2020-2025) & (US$ Million)
Table 65. Hoffmann-La Roche Ltd Recent Development
Table 66. Bio-Rad Laboratories, Inc Company Details
Table 67. Bio-Rad Laboratories, Inc Business Overview
Table 68. Bio-Rad Laboratories, Inc Whole Genome and Exome Sequencing Product
Table 69. Bio-Rad Laboratories, Inc Revenue in Whole Genome and Exome Sequencing Business (2020-2025) & (US$ Million)
Table 70. Bio-Rad Laboratories, Inc Recent Development
Table 71. GENEWIZ, Inc Company Details
Table 72. GENEWIZ, Inc Business Overview
Table 73. GENEWIZ, Inc Whole Genome and Exome Sequencing Product
Table 74. GENEWIZ, Inc Revenue in Whole Genome and Exome Sequencing Business (2020-2025) & (US$ Million)
Table 75. GENEWIZ, Inc Recent Development
Table 76. Illumina, Inc Company Details
Table 77. Illumina, Inc Business Overview
Table 78. Illumina, Inc Whole Genome and Exome Sequencing Product
Table 79. Illumina, Inc Revenue in Whole Genome and Exome Sequencing Business (2020-2025) & (US$ Million)
Table 80. Illumina, Inc Recent Development
Table 81. Laboratory Corporation of America Holdings Company Details
Table 82. Laboratory Corporation of America Holdings Business Overview
Table 83. Laboratory Corporation of America Holdings Whole Genome and Exome Sequencing Product
Table 84. Laboratory Corporation of America Holdings Revenue in Whole Genome and Exome Sequencing Business (2020-2025) & (US$ Million)
Table 85. Laboratory Corporation of America Holdings Recent Development
Table 86. Novogene Corporation Company Details
Table 87. Novogene Corporation Business Overview
Table 88. Novogene Corporation Whole Genome and Exome Sequencing Product
Table 89. Novogene Corporation Revenue in Whole Genome and Exome Sequencing Business (2020-2025) & (US$ Million)
Table 90. Novogene Corporation Recent Development
Table 91. Oxford Nanopore Technologies, Inc Company Details
Table 92. Oxford Nanopore Technologies, Inc Business Overview
Table 93. Oxford Nanopore Technologies, Inc Whole Genome and Exome Sequencing Product
Table 94. Oxford Nanopore Technologies, Inc Revenue in Whole Genome and Exome Sequencing Business (2020-2025) & (US$ Million)
Table 95. Oxford Nanopore Technologies, Inc Recent Development
Table 96. Pacific Biosciences of California, Inc Company Details
Table 97. Pacific Biosciences of California, Inc Business Overview
Table 98. Pacific Biosciences of California, Inc Whole Genome and Exome Sequencing Product
Table 99. Pacific Biosciences of California, Inc Revenue in Whole Genome and Exome Sequencing Business (2020-2025) & (US$ Million)
Table 100. Pacific Biosciences of California, Inc Recent Development
Table 101. QIAGEN N.V Company Details
Table 102. QIAGEN N.V Business Overview
Table 103. QIAGEN N.V Whole Genome and Exome Sequencing Product
Table 104. QIAGEN N.V Revenue in Whole Genome and Exome Sequencing Business (2020-2025) & (US$ Million)
Table 105. QIAGEN N.V Recent Development
Table 106. Thermo Fisher Scientific Inc Company Details
Table 107. Thermo Fisher Scientific Inc Business Overview
Table 108. Thermo Fisher Scientific Inc Whole Genome and Exome Sequencing Product
Table 109. Thermo Fisher Scientific Inc Revenue in Whole Genome and Exome Sequencing Business (2020-2025) & (US$ Million)
Table 110. Thermo Fisher Scientific Inc Recent Development
Table 111. Cytiva Company Details
Table 112. Cytiva Business Overview
Table 113. Cytiva Whole Genome and Exome Sequencing Product
Table 114. Cytiva Revenue in Whole Genome and Exome Sequencing Business (2020-2025) & (US$ Million)
Table 115. Cytiva Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report


List of Figures
Figure 1. Whole Genome and Exome Sequencing Picture
Figure 2. Global Whole Genome and Exome Sequencing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Whole Genome and Exome Sequencing Market Share by Type: 2024 VS 2031
Figure 4. By Product Features
Figure 5. By Workflow Features
Figure 6. Global Whole Genome and Exome Sequencing Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Whole Genome and Exome Sequencing Market Share by Application: 2024 VS 2031
Figure 8. Hospitals and Clinics Case Studies
Figure 9. Pharmaceutical and Biotechnology Companies Case Studies
Figure 10. Diagnostic Labs Case Studies
Figure 11. Research Centres, Academia and Government Institutes Case Studies
Figure 12. Others Case Studies
Figure 13. Whole Genome and Exome Sequencing Report Years Considered
Figure 14. Global Whole Genome and Exome Sequencing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Whole Genome and Exome Sequencing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Whole Genome and Exome Sequencing Market Share by Region: 2024 VS 2031
Figure 17. Global Whole Genome and Exome Sequencing Market Share by Players in 2024
Figure 18. Global Top Whole Genome and Exome Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Whole Genome and Exome Sequencing as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Whole Genome and Exome Sequencing Revenue in 2024
Figure 20. North America Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Whole Genome and Exome Sequencing Market Share by Country (2020-2031)
Figure 22. United States Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Whole Genome and Exome Sequencing Market Share by Country (2020-2031)
Figure 26. Germany Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Whole Genome and Exome Sequencing Market Share by Region (2020-2031)
Figure 34. China Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Whole Genome and Exome Sequencing Market Share by Country (2020-2031)
Figure 42. Mexico Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Whole Genome and Exome Sequencing Market Share by Country (2020-2031)
Figure 46. Turkey Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Eurofins Scientific SE Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2020-2025)
Figure 50. Agilent Technologies, Inc Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2020-2025)
Figure 51. Beijing Genomics Institute (BGI) Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2020-2025)
Figure 52. Hoffmann-La Roche Ltd Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2020-2025)
Figure 53. Bio-Rad Laboratories, Inc Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2020-2025)
Figure 54. GENEWIZ, Inc Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2020-2025)
Figure 55. Illumina, Inc Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2020-2025)
Figure 56. Laboratory Corporation of America Holdings Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2020-2025)
Figure 57. Novogene Corporation Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2020-2025)
Figure 58. Oxford Nanopore Technologies, Inc Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2020-2025)
Figure 59. Pacific Biosciences of California, Inc Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2020-2025)
Figure 60. QIAGEN N.V Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2020-2025)
Figure 61. Thermo Fisher Scientific Inc Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2020-2025)
Figure 62. Cytiva Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies